Evry, June 27, 2013. Généthon, the AFM-Telethon laboratory, has received the authorization delivered by
the National Agency for Drug Safety (ANSM) to become a pharmaceutical manufacturer. Its production
center, Généthon BioProd, is now authorized to produce drugs for innovative treatments. This is a first
for a laboratory created by an association of patients and financed thanks to the generosity of the public,
and a new stage in the emergence of innovative treatments for rare diseases.
Read the press release – 27/06/2013 (2 pages – 132 ko)